【captain in terminator armor datasheet】Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November
NEWTOWN,captain in terminator armor datasheet Pa., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:
HSDT
) (TSX:
HSM
) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that management will participate in the following upcoming investor conferences:
The Investor Summit Group’s Virtual Fall Summit, which is being held from November 16th - 18th.
Management will present on Tuesday, November 17th at 1:00 p.m. Eastern Time.
Alliance Global Partners’ Virtual Healthcare Symposium, which is being held on November 19th.
Management will participate in virtual 1x1 meetings on Thursday, November 19th. There will be no formal presentation.
The
Sidoti
& Co. Virtual Fall Microcap Conference, which is being held on November 19th.
Management will present on Thursday, November 19th at 9:15 a.m. Eastern Time.
Live audio webcasts of the presentations will be provided under the ‘Events’ section of the Helius Medical Technologies investor relations website at
https://heliusmedical.com/index.php/investor-relations/events/upcoming-events
. Archives of the webcasts will be available for replay following the conference.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS
TM
). For more information, visit
www.heliusmedical.com
.
About the PoNS™ Device and PoNS Treatment™
The Portable Neuromodulation Stimulator (PoNS™) is authorized for sale in Canada as a class II, non-implantable, medical device intended as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from multiple sclerosis (MS), and chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy. The PoNS™ is an investigational medical device in the United States, the European Union (“EU”), and Australia (“AUS”). The device is currently under review for clearance by the FDA. It is also under premarket review by the AUS Therapeutic Goods Administration. PoNS™ is currently not commercially available in the United States, the European Union or Australia.
Investor Relations Contact
:
Westwicke Partners on behalf of Helius Medical Technologies, Inc.
Mike Piccinino, CFA
View comments
-
SoftBank CEO Tells Wall Street He’s Eager to Keep InvestingEuro zone factories ended 2018 on a low note - PMIGalveston Attorney Charged With Representing Clients He'd Never MetWhat ROTC Programs Are and How They WorkGofore Plc: Gofore Plc - Managers' transactions - Virtanen10 Six-Figure Jobs That Don’t Require a Four-Year DegreeWhy Caesarstone Ltd. (NASDAQ:CSTE) Could Be Worth WatchingBRIEF-Jinhui Holdings Co Says Unit To Dispose Vessel To Poseidon Global Shipping Pte For $7.4 MlnFIRST FIRM TO INVESTIGATE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Carnival Corporation & Plc and Encourages Investors with Losses of $100,000 to Contact the Firm5 Top Stocks to Own This February
下一篇:Daseke Sees Flatbed Softness Continuing Through First Half Of 2020
- ·Nightfood Announces Rouses Markets as Newest Supermarket Distribution Partner
- ·Overseas unit of China's cigarette monopoly files for Hong Kong IPO
- ·Does West Bancorporation, Inc.’s (NASDAQ:WTBA) P/E Ratio Signal A Buying Opportunity?
- ·Netflix poaches CFO from Activision Blizzard - source
- ·Can Ero Copper Corp. (TSE:ERO) Maintain Its Strong Returns?
- ·Palm opens higher on India import tax cut, but gains seen limited
- ·3 Stock Charts for Wednesday: Dentsply, Procter & Gamble and Valero Energy
- ·Gold Jumps on Safe-Haven Demand, Drop in Saudi Exports Boosts Crude, Weather Woes Weigh on Natural Gas
- ·What Is Parker-Hannifin's (NYSE:PH) P/E Ratio After Its Share Price Tanked?
- ·Does West Bancorporation, Inc.’s (NASDAQ:WTBA) P/E Ratio Signal A Buying Opportunity?
- ·Trump: Falling gas prices are 'tax cut' for US consumers
- ·BRIEF-Rizhao Port's Controlling Shareholder's Unit Wins Project For 243.5 Million Yuan
- ·More drugmakers hike U.S. prices as new year begins
- ·Former Brexit minister says May should delay Brexit deal vote -the Telegraph
- ·Malaysia changes version of last words from missing flight's cockpit
- ·NEO Technical Analysis – Support Levels in Play – 01/02/19
- ·Gatling Discovers 3rd High-Grade Gold Trend at Kir Vit; Encounters Highest Grades to Date
- ·European VC trends in 9 charts
- ·Resolutions 2019: Budget Your Way to Financial Goals
- ·SE Asia Stocks-Singapore, Malaysia bruised by gloomy Chinese data
- ·Antibodies, Protein-based Vaccines, Anti-virals, and Cell-based Therapies to Lead the Development of COVID-19 Treatment Pipeline- Exclusive Report by Meticulous Research®
- ·Apache Canada Ltd Subject to AER Enforcement Action
- ·Thousands march in Hong Kong against China repression after grim 2018
- ·In packed churches and secret masses, papal visit brings Gulf Catholics hope
- ·5 Stocks With Decent Growth Potential to Watch Ahead
- ·BRIEF-Kweichow Moutai Sees 2018 Net Profit Up About 25 Pct Y/Y
- ·Is Now The Time To Look At Buying National Beverage Corp. (NASDAQ:FIZZ)?
- ·DJ Khaled Is Weight Watchers' Newest Social Media Ambassador
- ·Have Insiders Been Selling Risecomm Group Holdings Limited (HKG:1679) Shares This Year?
- ·VINCI : Implementation of the share buyback programme
- ·Labrador Iron Ore Royalty Corporation Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
- ·SNL 'Precap': 5 Sketches Claire Foy's Episode Just Has to Include
- ·Why Vita Life Sciences Limited (ASX:VLS) Looks Like A Quality Company
- ·Wednesday Newspaper
- ·Orkla ASA: Higher in-home consumption of food and cleaning products spurred growth for Orkla
- ·VINCI : Implementation of the share buyback programme